178 related articles for article (PubMed ID: 9632352)
1. A pyridoxine cyclic phosphate and its 6-azoaryl derivative selectively potentiate and antagonize activation of P2X1 receptors.
Jacobson KA; Kim YC; Wildman SS; Mohanram A; Harden TK; Boyer JL; King BF; Burnstock G
J Med Chem; 1998 Jun; 41(13):2201-6. PubMed ID: 9632352
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors.
Kim YC; Brown SG; Harden TK; Boyer JL; Dubyak G; King BF; Burnstock G; Jacobson KA
J Med Chem; 2001 Feb; 44(3):340-9. PubMed ID: 11462975
[TBL] [Abstract][Full Text] [Related]
3. Characterization of cultured dorsal root ganglion neuron P2X receptors.
Grubb BD; Evans RJ
Eur J Neurosci; 1999 Jan; 11(1):149-54. PubMed ID: 9987019
[TBL] [Abstract][Full Text] [Related]
4. Cloning, tissue distribution and functional characterization of the chicken P2X1 receptor.
Soto F; Krause U; Borchardt K; Ruppelt A
FEBS Lett; 2003 Jan; 533(1-3):54-8. PubMed ID: 12505158
[TBL] [Abstract][Full Text] [Related]
5. Lack of run-down of smooth muscle P2X receptor currents recorded with the amphotericin permeabilized patch technique, physiological and pharmacological characterization of the properties of mesenteric artery P2X receptor ion channels.
Lewis CJ; Evans RJ
Br J Pharmacol; 2000 Dec; 131(8):1659-66. PubMed ID: 11139444
[TBL] [Abstract][Full Text] [Related]
6. Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.
Kim HS; Ravi RG; Marquez VE; Maddileti S; Wihlborg AK; Erlinge D; Malmsjö M; Boyer JL; Harden TK; Jacobson KA
J Med Chem; 2002 Jan; 45(1):208-18. PubMed ID: 11754592
[TBL] [Abstract][Full Text] [Related]
7. Activation and desensitization of the recombinant P2X1 receptor at nanomolar ATP concentrations.
Rettinger J; Schmalzing G
J Gen Physiol; 2003 May; 121(5):451-61. PubMed ID: 12719485
[TBL] [Abstract][Full Text] [Related]
8. P2x-purinoceptors of myenteric neurones from the guinea-pig ileum and their unusual pharmacological properties.
Barajas-López C; Huizinga JD; Collins SM; Gerzanich V; Espinosa-Luna R; Peres AL
Br J Pharmacol; 1996 Dec; 119(8):1541-8. PubMed ID: 8982499
[TBL] [Abstract][Full Text] [Related]
9. P2X4, P2Y1 and P2Y2 receptors on rat alveolar macrophages.
Bowler JW; Bailey RJ; North RA; Surprenant A
Br J Pharmacol; 2003 Oct; 140(3):567-75. PubMed ID: 12970084
[TBL] [Abstract][Full Text] [Related]
10. P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels.
Nicke A; Bäumert HG; Rettinger J; Eichele A; Lambrecht G; Mutschler E; Schmalzing G
EMBO J; 1998 Jun; 17(11):3016-28. PubMed ID: 9606184
[TBL] [Abstract][Full Text] [Related]
11. Novel mechanism of inhibition by the P2 receptor antagonist PPADS of ATP-activated current in dorsal root ganglion neurons.
Li C
J Neurophysiol; 2000 May; 83(5):2533-41. PubMed ID: 10805655
[TBL] [Abstract][Full Text] [Related]
12. Purinergic and vanilloid receptor activation releases glutamate from separate cranial afferent terminals in nucleus tractus solitarius.
Jin YH; Bailey TW; Li BY; Schild JH; Andresen MC
J Neurosci; 2004 May; 24(20):4709-17. PubMed ID: 15152030
[TBL] [Abstract][Full Text] [Related]
13. Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2/3, and P2X3 and inhibitory P2Y1, P2Y2, and/or P2Y4 receptors in the rat hippocampus.
Rodrigues RJ; Almeida T; Richardson PJ; Oliveira CR; Cunha RA
J Neurosci; 2005 Jul; 25(27):6286-95. PubMed ID: 16000618
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of the P2X(4) receptor orthologues.
Jones CA; Chessell IP; Simon J; Barnard EA; Miller KJ; Michel AD; Humphrey PP
Br J Pharmacol; 2000 Jan; 129(2):388-94. PubMed ID: 10694247
[TBL] [Abstract][Full Text] [Related]
15. Functional evidence that ATP or a related purine is an inhibitory NANC neurotransmitter in the mouse jejunum: study on the identity of P2X and P2Y purinoceptors involved.
De Man JG; De Winter BY; Seerden TC; De Schepper HU; Herman AG; Pelckmans PA
Br J Pharmacol; 2003 Nov; 140(6):1108-16. PubMed ID: 14530212
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of pyridoxal phosphate derivatives with antagonist activity at the P2Y13 receptor.
Kim YC; Lee JS; Sak K; Marteau F; Mamedova L; Boeynaems JM; Jacobson KA
Biochem Pharmacol; 2005 Jul; 70(2):266-74. PubMed ID: 15913566
[TBL] [Abstract][Full Text] [Related]
17. Selective potentiation of homomeric P2X2 ionotropic ATP receptors by a fast non-genomic action of progesterone.
De Roo M; Boué-Grabot E; Schlichter R
Neuropharmacology; 2010 Mar; 58(3):569-77. PubMed ID: 20004677
[TBL] [Abstract][Full Text] [Related]
18. P19 embryonal carcinoma cells as in vitro model for studying purinergic receptor expression and modulation of N-methyl-D-aspartate-glutamate and acetylcholine receptors during neuronal differentiation.
Resende RR; Majumder P; Gomes KN; Britto LR; Ulrich H
Neuroscience; 2007 May; 146(3):1169-81. PubMed ID: 17418494
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships of bisphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists.
Nandanan E; Camaioni E; Jang SY; Kim YC; Cristalli G; Herdewijn P; Secrist JA; Tiwari KN; Mohanram A; Harden TK; Boyer JL; Jacobson KA
J Med Chem; 1999 May; 42(9):1625-38. PubMed ID: 10229631
[TBL] [Abstract][Full Text] [Related]
20. The purinergic component of human vas deferens contraction.
Banks FC; Knight GE; Calvert RC; Thompson CS; Morgan RJ; Burnstock G
Fertil Steril; 2006 Apr; 85(4):932-9. PubMed ID: 16580377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
